<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39438484</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery.</ArticleTitle><Pagination><StartPage>9119</StartPage><MedlinePgn>9119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-53569-8</ELocationID><Abstract><AbstractText>Lipid nanoparticles (LNPs) play a crucial role in addressing genetic disorders, and cancer, and combating pandemics such as COVID-19 and its variants. Yet, the ability of LNPs to effectively encapsulate large-size DNA molecules remains elusive. This is a significant limitation, as the successful delivery of large-size DNA holds immense potential for gene therapy. To address this gap, the present study focuses on the design of PEGylated LNPs, incorporating large-sized DNA, departing from traditional RNA and ionizable lipids. The resultant LNPs demonstrate a unique particle morphology. These particles were further engineered with a DNA coating and plasma proteins. This multicomponent bionanoconstruct exhibits enhanced transfection efficiency and safety in controlled laboratory settings and improved immune system evasion in in vivo tests. These findings provide valuable insights for the design and development of bionanoarchitectures for large-size DNA delivery, opening new avenues for transformative gene therapies.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Renzi</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Digiacomo</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3362-7160</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pozzi</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quagliarini</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vulpis</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuli</LastName><ForeName>Maria Valeria</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0003-2132-9369</Identifier><AffiliationInfo><Affiliation>Department of Medico-Surgical Sciences and Biotechnology, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Latina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancusi</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natiello</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pignataro</LastName><ForeName>Maria Gemma</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canettieri</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6694-2613</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Magno</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesce</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5863-399X</Identifier><AffiliationInfo><Affiliation>NEST, Scuola Normale Superiore, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Lorenzi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7429-6524</Identifier><AffiliationInfo><Affiliation>NEST, Scuola Normale Superiore, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghignoli</LastName><ForeName>Samuele</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NEST, Scuola Normale Superiore, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loconte</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montone</LastName><ForeName>Carmela Maria</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laura Capriotti</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laganà</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicoletti</LastName><ForeName>Carmine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5896-2040</Identifier><AffiliationInfo><Affiliation>Unit of Histology and Medical Embryology, Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amenitsch</LastName><ForeName>Heinz</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Inorganic Chemistry, Graz University of Technology, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7603-1805</Identifier><AffiliationInfo><Affiliation>Department of Basic and Applied Sciences for Engineering and Center for Nanotechnology Applied to Engineering (CNIS), Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mura</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Basic and Applied Sciences for Engineering and Center for Nanotechnology Applied to Engineering (CNIS), Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parisi</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Basic and Applied Sciences for Engineering and Center for Nanotechnology Applied to Engineering (CNIS), Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardarelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3049-5940</Identifier><AffiliationInfo><Affiliation>NEST, Scuola Normale Superiore, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zingoni</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0906-1566</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. alessandra.zingoni@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Checquolo</LastName><ForeName>Saula</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5109-8392</Identifier><AffiliationInfo><Affiliation>Department of Medico-Surgical Sciences and Biotechnology, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Latina, Italy. saula.checquolo@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caracciolo</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8636-4475</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. giulio.caracciolo@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000066970">Protein Corona</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000711949">Lipid Nanoparticles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>3WJQ0SDW1A</RegistryNumber><NameOfSubstance UI="D011092">Polyethylene Glycols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008081">Liposomes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066970" MajorTopicYN="Y">Protein Corona</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="Y">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018014" MajorTopicYN="Y">Gene Transfer Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="Y">Genetic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011092" MajorTopicYN="N">Polyethylene Glycols</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39438484</ArticleId><ArticleId IdType="pmc">PMC11496629</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-53569-8</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-53569-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cullis, P. R. &amp; Hope, M. J. Lipid nanoparticle systems for enabling gene therapies. Mol. Ther.25, 1467–1475 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5498813</ArticleId><ArticleId IdType="pubmed">28412170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni, J. A., Cullis, P. R. &amp; Van Der Meel, R. Lipid nanoparticles enabling gene therapies: from concepts to clinical utility. Nucleic Acid Therapeutics28, 146–157 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29683383</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol.14, 1084–1087 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31802031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokita, K., Inoue, J., Ishihara, H., Kojima, K. &amp; Inazawa, J. Therapeutic potential of LNP-mediated delivery of miR-634 for cancer therapy. Mol. Ther.-Nucleic Acids19, 330–338 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938807</ArticleId><ArticleId IdType="pubmed">31877409</ArticleId></ArticleIdList></Reference><Reference><Citation>Thi, T. T. H. et al. Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines9, 359 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8069344</ArticleId><ArticleId IdType="pubmed">33918072</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, J., Li, T. &amp; Zhu, J. Gene therapy strategies targeting aging-related diseases. Aging Dis.14, 398 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10017145</ArticleId><ArticleId IdType="pubmed">37008065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, Y. et al. Multi-step screening of DNA/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression. Nat. Commun.13, 4282 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9310361</ArticleId><ArticleId IdType="pubmed">35879315</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimaraes, L. C. et al. Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models. Nat. Commun.15, 590 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10796936</ArticleId><ArticleId IdType="pubmed">38238326</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz, C. &amp; Wagner, E. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. J. Control. Release161, 554–565 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22123560</ArticleId></ArticleIdList></Reference><Reference><Citation>Irobalieva, R. N. et al. Structural diversity of supercoiled DNA. Nat. Commun.6, 8440 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4608029</ArticleId><ArticleId IdType="pubmed">26455586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni, J. A. et al. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomed. Nanotechnol. Biol. Med.13, 1377–1387 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28038954</ArticleId></ArticleIdList></Reference><Reference><Citation>Algarni, A. et al. In vivo delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression. Biomater. Sci.10, 2940–2952 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35475455</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalzo, S. et al. Ionizable lipid nanoparticle-mediated delivery of plasmid DNA in cardiomyocytes. Int. J. Nanomed.30, 2865–2881 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9252585</ArticleId><ArticleId IdType="pubmed">35795081</ArticleId></ArticleIdList></Reference><Reference><Citation>Biscans, A., Ly, S., McHugh, N., Cooper, D. A. &amp; Khvorova, A. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo. J. Control. Release349, 831–843 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281028</ArticleId><ArticleId IdType="pubmed">35917865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R. &amp; van der Meel, R. Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Acc. Chem. Res.52, 2435–2444 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31397996</ArticleId></ArticleIdList></Reference><Reference><Citation>Quagliarini, E. et al. Mechanistic insights into the superior DNA delivery efficiency of multicomponent lipid nanoparticles: an in vitro and in vivo study. ACS Appl. Mater. Interfaces14, 56666–56677 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36524967</ArticleId></ArticleIdList></Reference><Reference><Citation>Giulimondi, F. et al. Opsonin-deficient nucleoproteic corona endows UnPEGylated liposomes with stealth properties in vivo. ACS Nano16, 2088–2100 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8867903</ArticleId><ArticleId IdType="pubmed">35040637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, V. et al. Shielding of lipid nanoparticles for siRNA delivery: impact on physicochemical properties, cytokine induction, and efficacy. Mol. Ther.-Nucleic Acids3, e210 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4459547</ArticleId><ArticleId IdType="pubmed">25405467</ArticleId></ArticleIdList></Reference><Reference><Citation>Schöttler, S., Landfester, K. &amp; Mailänder, V. Controlling the stealth effect of nanocarriers through understanding the protein corona. Angew. Chem. Int. Ed.55, 8806–8815 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27303916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke, P. C., Lin, S., Parak, W. J., Davis, T. P. &amp; Caruso, F. A decade of the protein corona. ACS Nano11, 11773–11776 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29206030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S. &amp; Agostini, M. Recent advances in understanding the protein corona of nanoparticles and in the formulation of “stealthy” nanomaterials. Front. Bioeng. Biotechnol.8, 166 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145938</ArticleId><ArticleId IdType="pubmed">32309278</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui, L. et al. Efficient delivery of DNA using lipid nanoparticles. Pharmaceutics14, 1698 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9416266</ArticleId><ArticleId IdType="pubmed">36015328</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam, K. et al. Unsaturated, trialkyl ionizable lipids are versatile lipid‐nanoparticle components for therapeutic and vaccine applications. Adv. Mater.35, 2209624 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36680477</ArticleId></ArticleIdList></Reference><Reference><Citation>Caracciolo, G., Pozzi, D., Caminiti, R. &amp; Amenitsch, H. Formation of overcharged cationic lipid/DNA complexes. Chem. Phys. Lett.429, 250–254 (2006).</Citation></Reference><Reference><Citation>Quagliarini, E. et al. Microfluidic formulation of DNA-loaded multicomponent lipid nanoparticles for gene delivery. Pharmaceutics13, 1292 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400491</ArticleId><ArticleId IdType="pubmed">34452253</ArticleId></ArticleIdList></Reference><Reference><Citation>Caracciolo, G. et al. Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density. J. Phys. Chem. B112, 11298–11304 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18707167</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchini, C. et al. Tailoring lipoplex composition to the lipid composition of plasma membrane: a trojan horse for cell entry? Langmuir26, 13867–13873 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20669909</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni, J. A. et al. On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA. ACS Nano12, 4787–4795 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29614232</ArticleId></ArticleIdList></Reference><Reference><Citation>Viger-Gravel, J. et al. Structure of lipid nanoparticles containing siRNA or mRNA by dynamic nuclear polarization-enhanced NMR spectroscopy. J. Phys. Chem. B122, 2073–2081 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29332384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro, L. Nd. M., Couto, V. M., Fraceto, L. F. &amp; De Paula, E. J. S. R. Use of nanoparticle concentration as a tool to understand the structural properties of colloids. Sci. Rep.8, 982 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5772370</ArticleId><ArticleId IdType="pubmed">29343691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternberg, B., Sorgi, F. L. &amp; Huang, L. New structures in complex formation between DNA and cationic liposomes visualized by freeze—fracture electron microscopy. FEBS Lett.356, 361–366 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7805873</ArticleId></ArticleIdList></Reference><Reference><Citation>Palchetti, S. et al. Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells. Nanomed. Nanotechnol. Biol. Med.13, 681–691 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27565691</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, N. &amp; Park, J.-H. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int. J. Nanomed.9, 51–63 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4024976</ArticleId><ArticleId IdType="pubmed">24872703</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolova, V. et al. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol.38, 1404–1413 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18389478</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedervall, T. et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl Acad. Sci. USA104, 2050–2055 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1892985</ArticleId><ArticleId IdType="pubmed">17267609</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson, K. A. &amp; Yan, Y. Current understanding of biological identity at the nanoscale and future prospects. Nat. Nanotechnol.16, 229–242 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33597736</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey, C. D. &amp; Chan, W. C. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev.41, 2780–2799 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22086677</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon, J. et al. Exploiting the biomolecular corona: pre-coating of nanoparticles enables controlled cellular interactions. Nanoscale10, 10731–10739 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29845991</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Magro, R. et al. Artificial apolipoprotein corona enables nanoparticle brain targeting. Nanomed.: Nanotechnol., Biol. Med.14, 429–438 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29157979</ArticleId></ArticleIdList></Reference><Reference><Citation>Giulimondi, F. et al. Interplay of protein corona and immune cells controls blood residency of liposomes. Nat. Commun.10, 1–11 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6695391</ArticleId><ArticleId IdType="pubmed">31417080</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvati, A. et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol.8, 137–143 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23334168</ArticleId></ArticleIdList></Reference><Reference><Citation>Nienhaus, K. &amp; Nienhaus, G. U. Mechanistic understanding of protein corona formation around nanoparticles: old puzzles and new insights. Small19, 2301663 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37010040</ArticleId></ArticleIdList></Reference><Reference><Citation>Digiacomo, L., Pozzi, D., Palchetti, S., Zingoni, A. &amp; Caracciolo, G. Impact of the protein corona on nanomaterial immune response and targeting ability. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol.12, e1615 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32003104</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y.-F. et al. The Yin and Yang of the protein corona on the delivery journey of nanoparticles. Nano Res.16, 715–734 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9483491</ArticleId><ArticleId IdType="pubmed">36156906</ArticleId></ArticleIdList></Reference><Reference><Citation>Digiacomo, L., Pozzi, D., Amenitsch, H. &amp; Caracciolo, G. Impact of the biomolecular corona on the structure of PEGylated liposomes. Biomater. Sci.5, 1884–1888 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28676869</ArticleId></ArticleIdList></Reference><Reference><Citation>Viard, M. et al. Design and biological activity of novel stealth polymeric lipid nanoparticles for enhanced delivery of hydrophobic photodynamic therapy drugs. Nanomed. Nanotechnol., Biol. Med.14, 2295–2305 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8034484</ArticleId><ArticleId IdType="pubmed">30059754</ArticleId></ArticleIdList></Reference><Reference><Citation>Caracciolo, G. et al. Lipid composition: a “key factor” for the rational manipulation of the liposome–protein corona by liposome design. RSC Adv.5, 5967–5975 (2015).</Citation></Reference><Reference><Citation>Caracciolo, G. et al. Evolution of the protein corona of lipid gene vectors as a function of plasma concentration. Langmuir27, 15048–15053 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22043822</ArticleId></ArticleIdList></Reference><Reference><Citation>Palchetti, S. et al. A mechanistic explanation of the inhibitory role of the protein corona on liposomal gene expression. Biochim. Biophys. Acta Biomembr.1862, 183159 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31857070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoli, F., Garry, D., Monopoli, M. P., Salvati, A. &amp; Dawson, K. A. The intracellular destiny of the protein corona: a study on its cellular internalization and evolution. ACS Nano10, 10471–10479 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27797479</ArticleId></ArticleIdList></Reference><Reference><Citation>Digiacomo, L., Digman, M. A., Gratton, E. &amp; Caracciolo, G. Development of an image Mean Square Displacement (iMSD)-based method as a novel approach to study the intracellular trafficking of nanoparticles. Acta Biomater.42, 189–198 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5483853</ArticleId><ArticleId IdType="pubmed">27449340</ArticleId></ArticleIdList></Reference><Reference><Citation>Digiacomo, L. et al. Dynamic fingerprinting of sub-cellular nanostructures by image mean square displacement analysis. Sci. Rep.7, 14836 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5665924</ArticleId><ArticleId IdType="pubmed">29093485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri, G. et al. Time-lapse confocal imaging datasets to assess structural and dynamic properties of subcellular nanostructures. Sci. Data5, 1–8 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142892</ArticleId><ArticleId IdType="pubmed">30226484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardarelli, F. et al. The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery. Sci. Rep.6, 25879 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4863168</ArticleId><ArticleId IdType="pubmed">27165510</ArticleId></ArticleIdList></Reference><Reference><Citation>Monopoli, M. P. et al. Physical− chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc.133, 2525–2534 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21288025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol.8, 772–781 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24056901</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier, T., Medjoubi-N, N. &amp; Porquet, D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta (BBA)-Protein Struct. Mol. Enzymol.1482, 157–171 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11058758</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Z. &amp; Ung, T. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics. Curr. Drug Metab.14, 226–238 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23092311</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng, Z. J., Liang, M., Monteiro, M., Toth, I. &amp; Minchin, R. F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol.6, 39–44 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21170037</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi, T. et al. Molecularly imprinted nanogels acquire stealth in situ by cloaking themselves with native dysopsonic proteins. Angew. Chem. Int. Ed.56, 7088–7092 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28455941</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochepied, T., Berger, F. G., Baumann, H. &amp; Libert, C. α1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev.14, 25–34 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12485617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan, S. et al. The “sweet” side of the protein corona: effects of glycosylation on nanoparticle–cell interactions. ACS Nano9, 2157–2166 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25599105</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanput, W., Mes, J. J. &amp; Wichers, H. J. THP-1 cell line: an in vitro cell model for immune modulation approach. Int. Immunopharmacol.23, 37–45 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25130606</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy, M., Eirikis, E., Davis, C., Davis, H. M. &amp; Prabhakar, U. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J. Immunol. Methods293, 127–142 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15541283</ArticleId></ArticleIdList></Reference><Reference><Citation>Betker, J. L. et al. Nanoparticle uptake by circulating leukocytes: a major barrier to tumor delivery. J. Control. Release286, 85–93 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6936323</ArticleId><ArticleId IdType="pubmed">30030182</ArticleId></ArticleIdList></Reference><Reference><Citation>Caracciolo, G. Artificial protein coronas: directing nanoparticles to targets. Trends Pharmacol. Sci.45, 602–613 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38811308</ArticleId></ArticleIdList></Reference><Reference><Citation>Digiacomo, L. et al. Optimal centrifugal isolating of liposome–protein complexes from human plasma. Nanoscale Adv.3, 3824–3834 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9418580</ArticleId><ArticleId IdType="pubmed">36133013</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenitsch, H. et al. First performance assessment of the small-angle X-ray scattering beamline at ELETTRA. J. Synchrotron Radiat.5, 506–508 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">15263560</ArticleId></ArticleIdList></Reference><Reference><Citation>Caracciolo, G. et al. Disease-specific protein corona sensor arrays may have disease detection capacity. Nanoscale Horiz.4, 1063–1076 (2019).</Citation></Reference><Reference><Citation>La Barbera, G. et al. Development of an enrichment method for endogenous phosphopeptide characterization in human serum. Anal. Bioanal. Chem.410, 1177–1185 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29318361</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova, S., Temu, T. &amp; Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc.11, 2301–2319 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27809316</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsch, E. W. et al. The ProteomeXchange consortium at 10 years: 2023 update. Nucleic Acids Res.51, D1539–D1548 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9825490</ArticleId><ArticleId IdType="pubmed">36370099</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, W. et al. Isolation and purification of immune cells from the liver. Int. Immunopharmacol.85, 106632 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32470880</ArticleId></ArticleIdList></Reference><Reference><Citation>Vulpis, E. et al. The possible role of sex as an important factor in development and administration of lipid nanomedicine-based COVID-19 vaccine. Mol. Pharm.18, 2448–2453 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33983745</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria, M. et al. Minimum information reporting in bio–nano experimental literature. Nat. Nanotechnol.13, 777–785 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6150419</ArticleId><ArticleId IdType="pubmed">30190620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>